BDBM92464 Carbenicillin
BRL-2064 Carbenicillin BDBM50377929 CARBENICILLIN DISODIUM CP-15-639-2
6beta-(2-carboxylato-2-phenylacetamido)-2,2-dimethylpenam-3alpha-carboxylate CARBENICILLIN CARBENICILLIN DISODIUM (2S,5R,6R)-6-{[carboxylato(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate BDBM50270009 carbenicillin(2-)
N-(4-tert-Butylbenzyl)-N'-[5-(methylsulfonylamino)-1-indanyl]thiourea BDBM50248811 CHEMBL475357
N-(4-tert-Butylbenzyl)-N'-[4-methoxy-5-(methylsulfonylamino)-1-indanyl] thiourea CHEMBL474773 BDBM50248813
N-(4-tert-Butylbenzyl)-N'-[6-methoxy-5-(methylsulfonylamino)-1-indanyl]thiourea CHEMBL474192 BDBM50248844
1-{N-[2-(Amidinoaminooxy)ethyl]amino}carbonylmethyl-6-methyl-3-(2-[5-indanyl]ethylamino)pyrazinone CHEMBL1087670 BDBM50312661
[(5-indanyl)aminomethylene]-1,1-bisphosphonate BDBM50138029 (2,3-dihydro-1H-inden-5-ylamino)methylenediphosphonic acid CHEMBL55889 [(Indan-5-ylamino)-phosphono-methyl]-phosphonic acid
BDBM50298999 CHEMBL584191 (A)-(4R)-3-(2-Benzyl-3-(2-(2,6-dimethylphenoxy)acetamido)-2-hydroxypropanoyl)-N-((1S,2R)-2-hydroxy-1-indanyl)-5,5-dimethylthiazolidine-4-carboxamide
US10174040, Comparative Example MLN4924 BDBM321058 N-[(1S)-1-indanyl]-7-[(1R)-3alpha-hydroxy-4∝-(sulfamoyloxymethyl)cyclopentyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine
CHEMBL584192 BDBM50299000 (B)-(4R)-3-(2-Benzyl-3-(2-(2,6-dimethylphenoxy)acetamido)-2-hydroxypropanoyl)-N-((1S,2R)-2-hydroxy-1-indanyl)-5,5-dimethylthiazolidine-4-carboxamide
N1,N6-Di[(2R)-hydroxy-(1S)-indanyl]-(2R,3R,4R,5R)-2,5-di(benzylsulfanyl)-3,4-dihydroxyhexanediamide Diol-Based HIV-1 protease inhibitor 8 (2R,3R,4R,5R)-2,5-bis(benzylsulfanyl)-3,4-dihydroxy-N,N'-bis[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]hexanediamide BDBM695
(2R,3R,4R,5R)-2,5-bis[(2,5-difluorophenyl)methoxy]-3,4-dihydroxy-N,N'-bis[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]hexanediamide 1-Valine Methylamide deriv. 17 N1,N6-Bis-[(2R)-hydroxy-1(S)-indanyl]-(2R,3R,4R,5R)-2.5-bis-(2,5-difluorobenzyloxy)-3,4-dihydroxyhexanediamide BDBM364
(2R,3R,4R,5R)-3,4-dihydroxy-N,N'-bis[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-2,5-bis(phenylsulfanyl)hexanediamide Diol-Based HIV-1 protease inhibitor 7 N1,N6-Di[(2R)-hydroxy-(1S)-indanyl]-(2R,3R,4R,5R)-3,4-dihydroxy-2,5-di(phenylsulfanyl)hexanediamide BDBM694
1-Valine Methylamide deriv. 13 N1,N6-Bis-[(2R)-hydroxy-1(S)-indanyl]-(2R,3R,4R,5R)-2.5-bis-(3-fluorobenzyloxy)-3,4-dihydroxyhexanediamide BDBM360 (2R,3R,4R,5R)-2,5-bis[(3-fluorophenyl)methoxy]-3,4-dihydroxy-N,N'-bis[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]hexanediamide
1-Valine Methylamide deriv. 14 N1,N6-Bis-[(2R)-hydroxy-1(S)-indanyl]-(2R,3R,4R,5R)-2.5-bis-(4-fluorobenzyloxy)-3,4-dihydroxyhexanediamide BDBM361 (2R,3R,4R,5R)-2,5-bis[(4-fluorophenyl)methoxy]-3,4-dihydroxy-N,N'-bis[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]hexanediamide
1-Valine Methylamide deriv. 15 BDBM362 N1,N6-Bis-[(2R)-hydroxy-1(S)-indanyl]-(2R,3R,4R,5R)-2.5-bis-(2,3-difluorobenzyloxy)-3,4-dihydroxyhexanediamide (2R,3R,4R,5R)-2,5-bis[(2,3-difluorophenyl)methoxy]-3,4-dihydroxy-N,N'-bis[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]hexanediamide
1-Valine Methylamide deriv. 16 N1,N6-Bis-[(2R)-hydroxy-1(S)-indanyl]-(2R,3R,4R,5R)-2.5-bis-(2,4-difluorobenzyloxy)-3,4-dihydroxyhexanediamide BDBM363 (2R,3R,4R,5R)-2,5-bis[(2,4-difluorophenyl)methoxy]-3,4-dihydroxy-N,N'-bis[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]hexanediamide
1-Valine Methylamide deriv. 18 (2R,3R,4R,5R)-2,5-bis[(2,6-difluorophenyl)methoxy]-3,4-dihydroxy-N,N'-bis[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]hexanediamide N1,N6-Bis-[(2R)-hydroxy-1(S)-indanyl]-(2R,3R,4R,5R)-2.5-bis-(2,6-difluorobenzyloxy)-3,4-dihydroxyhexanediamide BDBM365
1-Valine Methylamide deriv. 20 N1,N6-Bis-[(2R)-hydroxy-1(S)-indanyl]-(2R,3R,4R,5R)-2.5-bis-(3,5-difluorobenzyloxy)-3,4-dihydroxyhexanediamide (2R,3R,4R,5R)-2,5-bis[(3,5-difluorophenyl)methoxy]-3,4-dihydroxy-N,N'-bis[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]hexanediamide BDBM367
BDBM359 1-Valine Methylamide deriv. 12 N1,N6-Bis-[(2R)-hydroxy-1(S)-indanyl]-(2R,3R,4R,5R)-2.5-bis-(2-fluorobenzyloxy)-3,4-dihydroxyhexanediamide (2R,3R,4R,5R)-2,5-bis[(2-fluorophenyl)methoxy]-3,4-dihydroxy-N,N'-bis[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]hexanediamide
N1,N6-Bis-[(2R)-hydroxy-1(S)-indanyl]-(2R,3R,4R,5R)-2.5-bis-(3,4-difluorobenzyloxy)-3,4-dihydroxyhexanediamide 1-Valine Methylamide deriv. 19 BDBM366 (2R,3R,4R,5R)-2,5-bis[(3,4-difluorophenyl)methoxy]-3,4-dihydroxy-N,N'-bis[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]hexanediamide
(2R,3R,4R,5R)-2,5-bis[(2-fluorophenyl)sulfanyl]-3,4-dihydroxy-N,N'-bis[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]hexanediamide Diol-Based HIV-1 protease inhibitor 9 N1,N6-Di[(2R)-hydroxy-(1S)-indanyl]-(2R,3R,4R,5R)-2,5-di(2-fluorophenylsulfanyl)-3,4-dihydroxyhexanediamide BDBM696
(2R,3R,4R,5R)-3,4-dihydroxy-N,N'-bis[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-2,5-bis(2-phenylethyl)hexanediamide N1,N6 -Bis[(2R)-hydroxy-(1S)-indanyl]-(2R,3R,4R,5R)-3,4-dihydroxy-2,5-bis(2-phenylethyl)hexanediamide Diol-Based HIV-1 protease inhibitor 4 BDBM585
BDBM698 Diol-Based HIV-1 protease inhibitor 11 N1,N6-Di[(2R)-hydroxy-(1S)-indanyl]-(2R,3R,4R,5R)-3,4-dihydroxy-2,5-di(2-pyridylsulfanyl)hexanediamide (2R,3R,4R,5R)-3,4-dihydroxy-N,N'-bis[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-2,5-bis(pyridin-2-ylsulfanyl)hexanediamide
Diol-Based HIV-1 protease inhibitor 10 N1,N6-Di[(2R)-hydroxy-(1S)-indanyl]-(2R,3R,4R,5R)-2,5-di(2-fluorobenzylsulfanyl)-3,4-dihydroxyhexanediamide (2R,3R,4R,5R)-2,5-bis({[(2-fluorophenyl)methyl]sulfanyl})-3,4-dihydroxy-N,N'-bis[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]hexanediamide BDBM697
Diol-Based HIV-1 protease inhibitor 12 BDBM699 N1,N6-Di[(2R)-hydroxy-(1S)-indanyl]-(2R,3R,4R,5R)-2,5-di(allylsulfanyl)-3,4-dihydroxyhexanediamide (2R,3R,4R,5R)-3,4-dihydroxy-N,N'-bis[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-2,5-bis(prop-2-en-1-ylsulfanyl)hexanediamide
Diol-Based HIV-1 protease inhibitor 3 (2R,3R,4S,5R)-3,4-dihydroxy-N,N'-bis[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-2,5-bis(2-phenylethyl)hexanediamide N1,N6 -Bis[(2R)-hydroxy-(1S)-indanyl]-(2R,3R,4S,5R)-3,4-dihydroxy-2,5-bis(2-phenylethyl)hexanediamide BDBM584
BDBM700 (2R,3R,4R,5R)-3,4-dihydroxy-N,N'-bis[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-2,5-bis(thiophen-2-ylsulfanyl)hexanediamide N1,N6-Di[(2R)-hydroxy-(1S)-indanyl]-(2R,3R,4R,5R)-3,4-dihydroxy-2,5-di(thiophen-3-ylsulfanyl)hexanediamide Diol-Based HIV-1 protease inhibitor 13
BDBM879 tert-butyl N-[(2S,3S,5R)-5-benzyl-3-hydroxy-5-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}-1-(4-hydroxyphenyl)pentan-2-yl]carbamate L-685,434 deriv. 23 N-(2(R)-Hydroxy-1(S)-indanyl)-5(S)-[(tert-butyloxycarbonyl)amino]-4(S)-hydroxy-6-(4-hydroxyphenyl)-2-(R)-(phenylmethyl)hexanamide
C2-symmetric compound 10 (2R,3R,4R,5R)-3,4-dihydroxy-N,N'-bis[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-2,5-bis({[(2E)-3-phenylprop-2-en-1-yl]oxy})hexanediamide (2R,3R,4R,5R)-N1,N6-Bis[(1S,2R)-2-hydroxy-1-indanyl]-2,5-bis[(2E)-3-phenyl-2-propenyloxy]-3,4-dihydroxyhexane-1,6-diamide BDBM8002
(2R,3R,4R,5R)-2,5-bis({[(2E)-3-(4-fluorophenyl)prop-2-en-1-yl]oxy})-3,4-dihydroxy-N,N'-bis[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]hexanediamide BDBM8003 C2-symmetric compound 11 (2R,3R,4R,5R)-N1,N6-Bis[(1S,2R)-2-hydroxy-1-indanyl]-2,5-bis[(2E)-3-(4-fluorophenyl)-2-propenyloxy]-3,4-dihydroxyhexane-1,6-diamide
(2R,3R,4R,5R)-3,4-dihydroxy-N,N'-bis[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-2,5-bis({[(2E)-3-(4-methylphenyl)prop-2-en-1-yl]oxy})hexanediamide BDBM8004 (2R,3R,4R,5R)-N1,N6-Bis[(1S,2R)-2-hydroxy-1-indanyl]-2,5-bis[(2E)-3-(4-tolyl)-2-propenyloxy]-3,4-dihydroxyhexane-1,6-diamide C2-symmetric compound 12
(2R,3R,4R,5R)-N1,N6-Bis[(1S,2R)-2-hydroxy-1-indanyl]-2,5-bis[(2E,4E)-5-phenyl-pent-2,4-dienyloxy]-3,4-dihydroxy-hexane-1,6-diamide (2R,3R,4R,5R)-3,4-dihydroxy-N,N'-bis[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-2,5-bis({[(2E,4E)-5-phenylpenta-2,4-dien-1-yl]oxy})hexanediamide BDBM8010 C2-symmetric compound 18
(2R,3S,4S,1 S,2 R)-4-[[(1,1-Dimethylethoxy0carbonyl]amino]-3-hydroxy-2-[(4-methoxybenzyl)amino]-5-phenylpentan(2 -hydroxy-1 indanyl)amide 2-Aminobenzyl-Substituted AHPPA deriv. 7 tert-butyl N-[(2S,3R,4R)-3-hydroxy-4-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}-4-{[(4-methoxyphenyl)methyl]amino}-1-phenylbutan-2-yl]carbamate BDBM1193
2-{4-[(2R)-2-[(2S,3S)-3-{[(tert-butoxy)carbonyl]amino}-2-hydroxy-4-phenylbutyl]-2-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}ethyl]phenoxy}acetic acid L-685,434 deriv. 43 BDBM894 N-(2(R)-Hydroxy-1(S)-indanyl)-5(S)-[(tert-butyloxycarbonyl)amino]-4(S)-hydroxy-6-phenyl-2(R)-[[4-(carboxymethyl)phenyl]methyl]hexanamide
BDBM1053 tert-butyl N-[(2S,3S,5R)-5-{[4-(3,3-dimethoxypropyl)phenyl]methyl}-3-hydroxy-5-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}-1-phenylpentan-2-yl]carbamate Hydroxyethylene dipeptide isostere 42 N-[2(R)-Hydroxy-1(S)-indanyl]-5-(S)-[[(1,1-dimethylethoxy)carbonyl]amino]-4(S)-hydroxy-6-phenyl-2(R )-[[4-(3,3-dimethoxypropyl)phenyl]methyl]hexanamide
BDBM8014 (2R,3R,4R,5R)-N1,N6-Di[(1S,2R)-2-hydroxy-1-indanyl]-2,5-bis[(2E)-pent-2-en-4-ynyl]-3,4-dihydroxyhexane-1,6-diamide C2-symmetric compound 22 (2R,3R,4R,5R)-3,4-dihydroxy-N,N'-bis[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-2,5-bis[(2E)-pent-2-en-4-yn-1-yloxy]hexanediamide
BDBM885 tert-butyl N-[(2S,3S,5R)-5-({4-[2-(dimethylamino)ethoxy]phenyl}methyl)-3-hydroxy-5-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}-1-phenylpentan-2-yl]carbamate N-(2(R)-Hydroxy-1(S)-indanyl)-5(S)-[(tert-butyloxycarbonyl)amino]-4(S)-hydroxy-6-phenyl-2(R)-[[4-[2-(dimethylamino)ethoxy]phenyl]methl]hexanamide L-685,434 deriv. 33
CHEMBL366393 (2R,3R,4R,5R)-N1,N6-Bis[(1S,2R)-2-hydroxy-1-indanyl]-2,5-bis[(2E)-3-bromo-2-propenyloxy]-3,4-dihydroxyhexane-1,6-diamide BDBM8001 (2R,3R,4R,5R)-2,5-bis({[(2E)-3-bromoprop-2-en-1-yl]oxy})-3,4-dihydroxy-N,N'-bis[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]hexanediamide C2-symmetric compound 9
L-685,434 deriv. 44 N-(2(R)-Hydroxy-1(S)-indanyl)-5(S)-[(tert-butyloxycarbonyl)amino]-4(S)-hydroxy-6-phenyl-2(R)-[[4-(2-hydroxyethoxy)phenyl]methyl]hexanamide BDBM895 tert-butyl N-[(2S,3S,5R)-3-hydroxy-5-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}-5-{[4-(2-hydroxyethoxy)phenyl]methyl}-1-phenylpentan-2-yl]carbamate
N-[2(R)-Hydroxy-1(S)-indanyl]-5(S)-[[(1,1-dimethylethoxy)carbonyl]amino]-4(S)-hydroxy-6-phenyl-2(R)-[[4-(3-hydroxypropyl)phenyl]methyl]hexanamide L-693,549 BDBM1050 tert-butyl N-[(2S,3S,5R)-3-hydroxy-5-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}-5-{[4-(3-hydroxypropyl)phenyl]methyl}-1-phenylpentan-2-yl]carbamate
tert-butyl N-[(2S,3S,5R)-3-hydroxy-5-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}-1-(4-hydroxyphenyl)-5-[(4-hydroxyphenyl)methyl]pentan-2-yl]carbamate BDBM880 L-685,434 deriv. 24 N-(2(R)-Hydroxy-1(S)-indanyl)-5(S)-[(tert-butyloxycarbonyl)amino]-4(S)-hydroxy-6-(4-hydroxyphenyl)-2-(R)-[(4-hydroxyphenyl)methyl]hexanamide
(2R,3R,4R,5R)-N1,N6-Bis[(1S,2R)-2-hydroxy-1-indanyl]-2,5-bis[(2E)-3-(2,4-dimethoxy-3,5-pyrimidin)-2-propenyloxy]-3,4-dihydroxyhexane-1,6-diamide BDBM8006 C2-symmetric compound 14 (2R,3R,4R,5R)-2,5-bis({[(2E)-3-(2,4-dimethoxypyrimidin-5-yl)prop-2-en-1-yl]oxy})-3,4-dihydroxy-N,N'-bis[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]hexanediamide
(2R,3R,4R,5R)-N1,N6-Bis[(1S,2R)-2-hydroxy-1-indanyl]-2,5-bis[(2E)-5-trimethylsilyl-pent-2-en-4-ynyl]-3,4-dihydroxyhexane-1,6-diamide C2-symmetric compound 21 BDBM8013 (2R,3R,4R,5R)-3,4-dihydroxy-N,N'-bis[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-2,5-bis({[(2E)-5-(trimethylsilyl)pent-2-en-4-yn-1-yl]oxy})hexanediamide
BDBM8007 (2R,3R,4R,5R)-2,5-bis({[(2E)-3-(2H-1,3-benzodioxol-5-yl)prop-2-en-1-yl]oxy})-3,4-dihydroxy-N,N'-bis[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]hexanediamide (2R,3R,4R,5R)-N1,N6-Bis[(1S,2R)-2-hydroxy-1-indanyl]-2,5-bis[(2E)-3-(3,4-methylenedioxyphenyl)-2-propenyloxy]-3,4-dihydroxyhexane-1,6-diamide C2-symmetric compound 15
BDBM8008 (2R,3R,4R,5R)-3,4-dihydroxy-N,N'-bis[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-2,5-bis({[(2E)-3-(thiophen-3-yl)prop-2-en-1-yl]oxy})hexanediamide (2R,3R,4R,5R)-N1,N6-Bis[(1S,2R)-2-hydroxy-1-indanyl]-2,5-bis[(2E)-3-(3-thienyl)-2-propenyloxy]-3,4-dihydroxy-hexane-1,6-diamide C2-symmetric compound 16
BDBM886 tert-butyl N-[(2S,3S,5R)-3-hydroxy-5-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}-1-phenyl-5-({4-[2-(piperidin-1-yl)ethoxy]phenyl}methyl)pentan-2-yl]carbamate L-685,434 deriv. 34 N-(2(R)-Hydroxy-1(S)-indanyl)-5(S)-[(tert-butyloxycarbonyl)amino]-4(S)-hydroxy-6-phenyl-2(R)-[[4-[2-(1-piperidinyl)ethoxy]phenyl]methyl]hexanamide
BDBM887 N-(2(R)-Hydroxy-1(S)-indanyl)-5(S)-[(tert-butyloxycarbonyl)amino]-4(S)-hydroxy-6-phenyl-2(R)-[[4-[2-(1-pyrrolidinyl)ethoxy]phenyl]methyl]hexanamide tert-butyl N-[(2S,3S,5R)-3-hydroxy-5-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}-1-phenyl-5-({4-[2-(pyrrolidin-1-yl)ethoxy]phenyl}methyl)pentan-2-yl]carbamate L-685,434 deriv. 35
C2-symmetric compound 20 (2R,3R,4R,5R)-3,4-dihydroxy-N,N'-bis[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-2,5-bis({[(2E)-5-phenylpent-2-en-4-yn-1-yl]oxy})hexanediamide BDBM8012 (2R,3R,4R,5R)-N1,N6-Bis[(1S,2R)-2-hydroxy-1-indanyl]-2,5-bis[(2E)-5-phenyl-pent-2-en-4-ynyl]-3,4-dihydroxyhexane-1,6-diamide
N-(2(R)-Hydroxy-1(S)-indanyl)-5(S)-[(tert-butyloxycarbonyl)amino]-4(S)-hydroxy-6-[4-[[3-(4-morpholinyl)propyl]oxy]phenyl]-2(R)-(phenylmethyl)hexanamide L-685,434 deriv. 32 BDBM884 tert-butyl N-[(2S,3S,5R)-3-hydroxy-5-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}-5-({4-[3-(morpholin-4-yl)propoxy]phenyl}methyl)-1-phenylpentan-2-yl]carbamate
tert-butyl N-[(2S,3S,5R)-3-hydroxy-5-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}-1-phenyl-5-[(2E)-3-phenylprop-2-en-1-yl]pentan-2-yl]carbamate CHEMBL265514 BDBM1031 N-[2(R)-Hydroxy-1(S)-indanyl]-5(S)-[[(1,1-dimethylethoxy)carbonyl]amino]-4(S)-hydroxy-6-phenyl-2(R)-(3-phenylprop-2-en-1-y1)hexanamide Hydroxyethylene dipeptide isostere 8
tert-butyl N-[(2S,3S,5R)-3-hydroxy-5-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}-5-({4-[2-(morpholin-4-yl)ethoxy]phenyl}methyl)-1-phenylpentan-2-yl]carbamate N-(2(R)-Hydroxy-1(S)-indanyl)-5(S)-[(tert-butyloxycarbonyl)amino]-4(S)-hydroxy-6-phenyl-2(R)-[[4-[2-(4-morpholinyl)ethoxy]phenyl]methl]hexanamide L-685,434 derivative L-689,502 BDBM881
tert-butyl N-[(2S,3S,5R)-5-benzyl-3-hydroxy-5-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}-1-{4-[2-(morpholin-4-yl)ethoxy]phenyl}pentan-2-yl]carbamate L-685,434 deriv. 30 N-(2(R)-Hydroxy-1(S)-indanyl)-5(S)-[(tert-butyloxycarbonyl)amino]-4(S)-hydroxy-6-[4-[2-[(4-morpholinyl)ethoxy]phenyl]-2-(R)-(phenylmethyl)hexanamide BDBM882
BDBM1032 Hydroxyethylene dipeptide isostere 24 N-[2(R)-Hydroxy-1( S)-indanyl]-5(S)-[[(1,1-dimethylethoxy)carbonyl]amino]-4( S)-hydroxy-6-phenyl-2(R)-(3-(4-hydroxyphenyl)prop-2-en-l-yl)hexanamide tert-butyl N-[(2S,3S,5R)-3-hydroxy-5-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}-5-[(2E)-3-(4-hydroxyphenyl)prop-2-en-1-yl]-1-phenylpentan-2-yl]carbamate
BDBM8009 (2R,3R,4R,5R)-2,5-bis({[(2E)-3-(3,5-dimethyl-1,2-oxazol-4-yl)prop-2-en-1-yl]oxy})-3,4-dihydroxy-N,N'-bis[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]hexanediamide C2-symmetric compound 17 (2R,3R,4R,5R)-N1,N6-Bis[(1S,2R)-2-hydroxy-1-indanyl]-2,5-bis[(2E)-3-(2,5-dimethyl-3,4-oxazol)-2-propenyloxy]-3,4-dihydroxyhexane-1,6-diamide
BDBM888 N-(2(R)-Hydroxy-1(S)-indanyl)-5(S)-[(tert-butyloxycarbonyl)amino]-4(S)-hydroxy-6-phenyl-2(R)-[[4-[2-(4-methylpiperazin-1-yl)ethoxy]phenyl]methyl]hexanamide tert-butyl N-[(2S,3S,5R)-3-hydroxy-5-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}-5-({4-[2-(4-methylpiperazin-1-yl)ethoxy]phenyl}methyl)-1-phenylpentan-2-yl]carbamate L-685,434 deriv. 36
BDBM889 N-(2(R)-Hydroxy-1(S)-indanyl)-5(S)-[(tert-butyloxycarbonyl)amino]-4(S)-hydroxy-6-phenyl-2(R)-[[4-[2-[N,N-bis(2-methoxyethyl)amino]ethoxy]phenyl]methyl]hexanamide tert-butyl N-[(2S,3S,5R)-5-[(4-{2-[bis(2-methoxyethyl)amino]ethoxy}phenyl)methyl]-3-hydroxy-5-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}-1-phenylpentan-2-yl]carbamate L-685,434 deriv. 37
L-685,434 deriv. 38 tert-butyl N-[(2S,3S,5R)-3-hydroxy-5-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}-1-phenyl-5-({4-[2-(thiomorpholin-4-yl)ethoxy]phenyl}methyl)pentan-2-yl]carbamate BDBM890 N-(2(R)-Hydroxy-1(S)-indanyl)-5(S)-[(tert-butyloxycarbonyl)amino]-4(S)-hydroxy-6-phenyl-2(R)-[[4-[2-(thiamorpholin-4-yl)ethoxy]phenyl]methyl]hexanamide
L-685,434 deriv. 39 N-(2(R)-Hydroxy-1(S)-indanyl)-5(S)-[(tert-butyloxycarbonyl)amino]-4(S)-hydroxy-6-phenyl-2(R)-[[4-[2-(1-oxothiamorpholin-4-yl)ethoxy]phenyl]methyl]hexanamide tert-butyl N-[(2S,3S,5R)-3-hydroxy-5-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}-5-({4-[2-(1-oxo-1,4-thiomorpholin-4-yl)ethoxy]phenyl}methyl)-1-phenylpentan-2-yl]carbamate BDBM891
L-685,434 deriv. 41 N-(2(R)-Hydroxy-1(S)-indanyl)-5(S)-[(tert-butyloxycarbonyl)amino]-4(S)-hydroxy-6-phenyl-2(R)-[[4-[2-(4-oxo-4-morpholinyl)ethoxy]phenyl]methyl]hexanamide 4-(2-{4-[(2R)-2-[(2S,3S)-3-{[(tert-butoxy)carbonyl]amino}-2-hydroxy-4-phenylbutyl]-2-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}ethyl]phenoxy}ethyl)-4-hydroxymorpholin-4-ium BDBM893
N-(2(R)-Hydroxy-1(S)-indanyl)-5(S)-[(tert-butyloxycarbonyl)amino]-4(S)-hydroxy-6-phenyl-2(R)-[[4-[2-(1,1-dioxythiamorpholin-4-yl)ethoxy]phenyl]methyl]hexanamide L-685,434 deriv. 40 tert-butyl N-[(2S,3S,5R)-5-({4-[2-(1,1-dioxo-1,4-thiomorpholin-4-yl)ethoxy]phenyl}methyl)-3-hydroxy-5-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}-1-phenylpentan-2-yl]carbamate BDBM892
methyl (2E,4E)-6-[(1R,2R,3R,4R)-2,3-dihydroxy-1,4-bis({[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl})-4-{[(2E,4E)-6-methoxy-6-oxohexa-2,4-dien-1-yl]oxy}butoxy]hexa-2,4-dienoate BDBM8011 C2-symmetric compound 19 (2R,3R,4R,5R)-N1,N6-Bis[(1S,2R)-2-hydroxy-1-indanyl]-2,5-bis[(2E,4E)-5-(methoxycarbonyl)-pent-2,4-dienyloxy]-3,4-dihydroxyhexane-1,6-diamide
tert-butyl N-[(2S,3S,5R)-3-hydroxy-5-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}-5-({4-[2-(morpholin-4-yl)-2-oxoethoxy]phenyl}methyl)-1-phenylpentan-2-yl]carbamate BDBM896 L-685,434 deriv. 45 N-(2(R)-Hydroxy-1(S)-indanyl)-5(S)-[(tert-butyloxycarbonyl)amino]-4(S)-hydroxy-6-phenyl-2(R)-[[4-[2-oxo-2-(4-morpholinyl)ethoxy]phenyl]methyl]hexanamide
Hydroxyethylene dipeptide isostere 25 BDBM1033 tert-butyl N-[(2S,3S,5R)-3-hydroxy-5-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}-5-[(2E)-3-{4-[2-(morpholin-4-yl)ethyl]phenyl}prop-2-en-1-yl]-1-phenylpentan-2-yl]carbamate N-[2(R)-Hydroxy-1(S)-indanyl]-5(S)-[[(1,1-dimethylethoxy)carbonyl]amino]-4(S)-hydroxy-6-phenyl-2(R)-[3-[4(morpholinoethoxy)phenyl]prop-2-en-1-yl] hexanamide
sodium;(2S,5R,6R)-6-[(2-carboxylato-2-phenyl-acetyl)amino]-7-keto-3,3-dimethyl-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate cid_657287 SMR000058569 CARBENICILLIN DISODIUM SALT MLS000069504 BDBM37634 sodium;(2S,5R,6R)-3,3-dimethyl-6-[(3-oxidanidyl-3-oxidanylidene-2-phenyl-propanoyl)amino]-7-oxidanylidene-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate sodium;(2S,5R,6R)-6-[(2-carboxylato-2-phenylacetyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate sodium;(2S,5R,6R)-6-[(2-carboxylato-1-oxo-2-phenylethyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
(2R,3S,4S,1 S,2 R)-2-[[4-[[[2-(Benzimidazol-2-yl)propionyl]amino]methyl]benzyl]zmino]-4-[[(1,1-dimethylethoxy)carbonyl]amino]-3-hydroxy-5-phenylpentan(2 -hydroxy-1 indanyl)amide tert-butyl N-[(2S,3R,4R)-4-{[(4-{[3-(1H-1,3-benzodiazol-2-yl)propanamido]methyl}phenyl)methyl]amino}-3-hydroxy-4-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}-1-phenylbutan-2-yl]carbamate 2-Aminobenzyl-Substituted AHPPA deriv. 23 BDBM1206
tert-butyl N-[(2S,3S,5R)-3-hydroxy-5-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}-1-{4-[2-(morpholin-4-yl)ethoxy]phenyl}-5-({4-[2-(morpholin-4-yl)ethoxy]phenyl}methyl)pentan-2-yl]carbamate L-685,434 deriv. 31 N-(2(R)-Hydroxy-1(S)-indanyl)-5(S)-[(tert-butyloxycarbonyl)amino]-4(S)-hydroxy-6-[4-[2-(4-morpholinyl)ethoxy]phenyl]-2-(R)-[[4-[2-(4-morphholinyl)ethoxy]phenyl]methyl]hexanamide BDBM883
- Mattson, RJ; Catt, JD; Keavy, D; Sloan, CP; Epperson, J; Gao, Q; Hodges, DB; Iben, L; Mahle, CD; Ryan, E; Yocca, FD Indanyl piperazines as melatonergic MT2 selective agents. Bioorg Med Chem Lett 13: 1199-202 (2003)
- Tian, J; Sun, N; Yu, M; Gu, X; Xie, Q; Shao, L; Liu, J; Liu, L; Wang, Y Discovery of N-indanyl benzamides as potent ROR?t inverse agonists. Eur J Med Chem 167: 37-48 (2019)
- Kobayashi, JI; Hirasawa, H; Fujimori, Y; Nakanishi, O; Kamada, N; Ikeda, T; Yamamoto, A; Kanbe, H Identification of N-acyl-N-indanyl-?-phenylglycinamides as selective TRPM8 antagonists designed to mitigate the risk of adverse effects. Bioorg Med Chem 30: (2021)
- Bialy, L; Pernerstorfer, J; Wirth, K; Steinmeyer, K; Hessler, G Indanyl-substituted 4,5,6,7-tetrahydro-1H-pyrazolo[4,3-C]pyridines, their use as medicament, and pharmaceutical preparations comprising them US Patent US9034897 (2015)
- Kokkonda, S; Deng, X; White, KL; Coteron, JM; Marco, M; de Las Heras, L; White, J; El Mazouni, F; Tomchick, DR; Manjalanagara, K; Rudra, KR; Chen, G; Morizzi, J; Ryan, E; Kaminsky, W; Leroy, D; Martínez-Martínez, MS; Jimenez-Diaz, MB; Bazaga, SF; Angulo-Barturen, I; Waterson, D; Burrows, JN; Matthews, D; Charman, SA; Phillips, MA; Rathod, PK Tetrahydro-2-naphthyl and 2-Indanyl Triazolopyrimidines Targeting Plasmodium falciparum Dihydroorotate Dehydrogenase Display Potent and Selective Antimalarial Activity. J Med Chem 59: 5416-31 (2016)
- Kawahara, I; Kato, Y; Suzuki, H; Achira, M; Ito, K; Crespi, CL; Sugiyama, Y Selective inhibition of human cytochrome P450 3A4 by N-[2(R)-hydroxy-1(S)-indanyl]-5-[2(S)-(1, 1-dimethylethylaminocarbonyl)-4-[(furo[2, 3-b]pyridin-5-yl)methyl]piperazin-1-yl]-4(S)-hydroxy-2(R)-phenylmethy lpentanamide and P-glycoprotein by valspodar in gene transfectant systems. Drug Metab Dispos 28: 1238-43 (2000)